These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7818588)

  • 1. Tolerability, pharmacokinetics and dose linearity of azelastine hydrochloride in healthy subjects.
    Riethmüller-Winzen H; Peter G; Büker KM; Romeis P; Borbe HO
    Arzneimittelforschung; 1994 Oct; 44(10):1136-40. PubMed ID: 7818588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and pharmacokinetics of single and multiple doses of azelastine hydrochloride in elderly volunteers.
    Peter G; Romeis P; Borbe HO; Büker KM; Riethmüller-Winzen H
    Arzneimittelforschung; 1995 May; 45(5):576-81. PubMed ID: 7612056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose related protective effect of azelastine on histamine induced bronchoconstriction in extrinsic asthma.
    Bauer K; Aurich R; Kaik G
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):333-8. PubMed ID: 1980266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
    Lefebvre RA; Rosseel MT; Bernheim J
    Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
    Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
    Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L; Andersson M; Svensson C; Persson CG
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design.
    Du D; Targett D; Stolberg E; Canali A
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):69-75. PubMed ID: 23681835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.
    Farré M; Roset PN; Llorente M; Márquez M; Albet C; Pérez JA; Herrero E; Ortíz JA
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):343-50. PubMed ID: 9379783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence evaluation of two different oral formulations of loperamide (Diarex Lactab vs Imodium capsules).
    Doser K; Meyer B; Nitsche V; Binkert-Graber P
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):431-6. PubMed ID: 8556221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
    Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.
    Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B
    Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.